Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 17/09/2024
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Next AGM date
18/09/2024
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
1,867.55 | 2,173.36 | 359.00 | 396.97 | -9.56 | 4 | 0.78 | Jun, Nov | 0.9 (31/03/2024) |
Scroll
Dividends
Dividends declared in last 12 months
Ex-Dividend date | Payment date | Dividend amount | Special dividend | Financial year |
---|---|---|---|---|
13/06/2024 | 24/07/2024 | 2.100 | No | 2024 |
23/11/2023 | 11/01/2024 | 0.700 | No | 2024 |
Scroll
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Worldwide Healthcare Trust | Share price total return | 15.3 | -0.5 | 38.4 | 166.4 |
Biotechnology & Healthcare AIC sector | Share price total return | 12.5 | -10.7 | 9.0 | 115.7 |
Scroll
Share structure
Number of shares
520,207,640
81,457,560
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 1,009,365 | 21,071,105 | 303,767,441 | 1,425,392,110 |
Average | N/A | 1,051,450 | 1,199,910 | 1,129,930 |
Scroll
Traded values (m)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 3.62 | 76.27 | 998.35 | 4,751.37 |
Average | N/A | 3.80 | 3.94 | 3.77 |
Scroll
Trading details
Top holdings
Data as at : 31/05/2024
Investment | % of total assets |
---|---|
Eli Lilly and Co | 8.9 |
Boston Scientific Corp | 7.5 |
AstraZeneca PLC | 7.2 |
Novo Nordisk A/S Class B | 6.7 |
Intuitive Surgical Inc | 6.0 |
Merck & Co Inc | 5.4 |
Tenet Healthcare Corp | 5.0 |
Biogen Inc | 4.7 |
Daiichi Sankyo Co Ltd | 4.2 |
Other Assets And Liabilities | -6.1 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.